Cannabis Freedom Index
← History

Legalisation 🇨🇭 Switzerland

Switzerland allows pilot trials of legal sales

A temporary provision allowed federally approved scientific trials of controlled cannabis sales to adults who already used cannabis. The law ran for ten years, while each trial was limited to five years with a possible two-year extension and at most 5,000 participants. The first regulated purchases followed in Basel in 2023.[1][3][4]

The story · written by gpt-6,

Switzerland opened a route to legal adult cannabis purchases through scientific studies on 15 May 2021. Parliament had approved the experimental provision the previous September, and the Federal Council adopted its implementing ordinance in March. The aim was to learn how controlled supply affected people who already used cannabis and the communities around them.[1][2]

A purchase became part of a study

The new route put a research project between a buyer and a seller. An adult had to join an authorised trial, already use cannabis and live in the participating canton. Each project needed federal approval, health safeguards and a plan for collecting evidence. Participation brought access to specified products and trained staff at an approved outlet.[3]

The federal health office described the existing illicit market as a problem: people were buying cannabis without reliable product controls. Within a trial, the supply chain could be followed from cultivation to sale, giving researchers a way to study an alternative under defined conditions.[3]

Ten years for the law, fewer for each trial

The enabling law had a ten-year window, ending on 14 May 2031. Individual trials could run for five years, with a justified extension of up to two more, and enrol no more than 5,000 people each. Those separate clocks limited both the experiment as a whole and any one local project.[1][3]

Different outlets made comparison possible. The authorised projects included pharmacy supply, specialist stores, associations and Zurich’s drug information centre. Researchers could examine how advice, organisation and the sales model shaped participants’ experience, alongside the cannabis itself.[4]

What the first participants could show

The first regulated sales in Basel began in 2023. By June 2025, seven ongoing trials contained about 10,400 adults. A university evaluation covering evidence through July reported that legal outlets had become the main supply source for most participants, while purchases from the illegal market had become less important.[4][5]

These were early findings from enrolled users. The evaluators combined trial information, case studies and expert interviews, with attention to health, public order and the different models of sale. Their work supplied evidence for the wider reform debate while the projects continued collecting data.[5]

For participants, the immediate change was practical: a controlled product and an authorised seller. For Switzerland, the trials created a way to test supply arrangements before deciding the shape of a wider cannabis market.[1][4]

Listed for context. No score change is recorded for Switzerland here.

References

  1. Federal Office of Public Health — Pilot trials with cannabis, legal basisarchived
  2. Federal Council — Pilot trials of controlled cannabis supply can start from May, 31 March 2021archived
  3. Federal Office of Public Health — FAQs on cannabis pilot trialsarchived
  4. Federal Office of Public Health — Overview of authorised pilot trialsarchived
  5. Hadorn, Mavrot and Novet — Analysis of Results from Cannabis Pilot Trials in Swiss Cities, Part Two, executive summary2025 · Abstract and sections on trial conditions and methodsarchived

Checked. The date and the event were compared with a source that was read.

    ↑↓ to move, ↵ to open.